Juvenile
-
Living Cell Technologies Receives Grant for Diabetes Clinical Trial
Living Cell Technologies has received a grant of US$500,000 for its on-going Phase II clinical trial of Diabecell in New Zealand from the Juvenile Diabetes Research Foundation International (JDRF). The first four patients have already received im…
Juvenile | 06 May 2010
-
Wyeth Receives Approval for Arthritis Drug
Wyeth has received approval from the Japanese Ministry of Health, Labor and Welfare to add the indication of treating polyarticular Juvenile Idiopathic Arthritis (JIA) to “Enbrel 25mg for SC Injection,†(etanercept). The company also received…
Juvenile | 23 July 2009
